Literature DB >> 30947834

Portal Hypertension and Related Complications: Diagnosis and Management.

Douglas A Simonetto1, Mengfei Liu2, Patrick S Kamath2.   

Abstract

Portal hypertension is a major complication of cirrhosis, and its consequences, including ascites, esophageal varices, hepatic encephalopathy, and hepatorenal syndrome, lead to substantial morbidity and mortality. The past several decades have seen major improvements in the clinical management of complications of portal hypertension, resulting in substantial gains in patient outcomes. However, important challenges remain. This review focuses on the pathophysiology and diagnosis of portal hypertension and discusses general approaches in the management of patients with ascites as a result of portal hypertension.
Copyright © 2019 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2019        PMID: 30947834     DOI: 10.1016/j.mayocp.2018.12.020

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  17 in total

1.  MR elastography, T1 and T2 relaxometry of liver: role in noninvasive assessment of liver function and portal hypertension.

Authors:  David H Hoffman; Abimbola Ayoola; Dominik Nickel; Fei Han; Hersh Chandarana; James Babb; Krishna Prasad Shanbhogue
Journal:  Abdom Radiol (NY)       Date:  2020-09

2.  Antihypertensive Effects of IGTGIPGIW Peptide Purified from Hippocampus abdominalis: p-eNOS and p-AKT Stimulation in EA.hy926 Cells and Lowering of Blood Pressure in SHR Model.

Authors:  Hyo-Geun Lee; Hyun-Soo Kim; Hyesuck An; Kyunghwa Baek; Jeong Min Lee; Mi-Jin Yim; Seok-Chun Ko; Ji-Yul Kim; Gun-Woo Oh; Jun-Geon Je; Dae-Sung Lee; You-Jin Jeon
Journal:  Mar Drugs       Date:  2022-05-26       Impact factor: 6.085

3.  Endothelin-1 in portal hypertension: The intricate role of hepatic stellate cells.

Authors:  Devaraj Ezhilarasan
Journal:  Exp Biol Med (Maywood)       Date:  2020-08-13

4.  The Role of Magnetic Resonance Elastography in the Diagnosis of Noncirrhotic Portal Hypertension.

Authors:  Patrick J Navin; Tolga Gidener; Alina M Allen; Meng Yin; Naoki Takahashi; Michael S Torbenson; Patrick S Kamath; Richard L Ehman; Sudhakar K Venkatesh
Journal:  Clin Gastroenterol Hepatol       Date:  2019-10-17       Impact factor: 11.382

5.  Prediction of overt hepatic encephalopathy after transjugular intrahepatic portosystemic shunt treatment: a cohort study.

Authors:  Yang Yang; Sirui Fu; Bin Cao; Kenan Hao; Yong Li; Jianwen Huang; Wenfeng Shi; Chongyang Duan; Xiao Bai; Kai Tang; Shirui Yang; Xiaofeng He; Ligong Lu
Journal:  Hepatol Int       Date:  2021-05-11       Impact factor: 6.047

Review 6.  Management of Liver Decompensation in Advanced Chronic Liver Disease: Ascites, Hyponatremia, and Gastroesophageal Variceal Bleeding.

Authors:  Anna Baiges; Virginia Hernández-Gea
Journal:  Clin Drug Investig       Date:  2022-04-27       Impact factor: 3.580

7.  Hypothyroidism Manifesting as a Combination of Ascites and Malnutrition Requiring Total Parenteral Nutrition: A Unique Presentation.

Authors:  Yousaf Zafar; Stephanie R Suddaby; Muhammad Shafiq
Journal:  Cureus       Date:  2019-08-07

8.  Validation and comparison of non-invasive prediction models based on liver stiffness measurement to identify patients who could avoid gastroscopy.

Authors:  Youwen Hu; Zhili Wen
Journal:  Sci Rep       Date:  2021-01-08       Impact factor: 4.379

9.  Clinical study on cystogastrostomy and Roux-en-Y-type cystojejunostomy in the treatment of pancreatic pseudocyst: A single-center experience.

Authors:  Jun Ye; Lan Wang; Shan Lu; Dujiang Yang; Weiming Hu; Huimin Lu; Yi Zhang
Journal:  Medicine (Baltimore)       Date:  2021-03-12       Impact factor: 1.817

10.  Hemodynamic Evaluation of the Right Heart-Pulmonary Circulation Unit in Patients Candidate to Transjugular Intrahepatic Portosystemic Shunt.

Authors:  Giulia Manguso; Anthony Vignone; Manuela Merli; Cristiano Miotti; Annalisa Caputo; Carmine Dario Vizza; Roberto Badagliacca
Journal:  J Clin Med       Date:  2022-01-17       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.